Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin adjunctive therapy for periodontitis non-responsive to initial periodontal therapy
ACTRN12619000597190Phase 3Not yet recruiting
- Sponsor
- The University of Queensland
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in periodontitis comparing Azithromycin plus periodontal debridement with Placebo plus periodontal debridement (2 arms). Primary endpoint: Change in clinical attachment level in residual periodontal pockets >=6 mm. Planned start Apr 2019; status: not yet recruiting.
02
Drugs
azithromycin
03
Conditions
periodontitis
Beyond the preview
Go deeper on ACTRN12619000597190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619000597190.